For the ever-growing number of patients with brain tumors, the need for better treatments and management strategies is acute. By combining laboratory and clinical data, we are able to provide an avenue toward therapies tailored to individual patients.
With the goal of targeting cancer at the molecular level, world-renowned physician/scientist Dr. Santosh Kesari heads up a team of scientists experienced in neuro-oncology and neurotherapeutics research.
The John Wayne Cancer Institute Auxiliary (JWCIA) honored neurologist and neuro-oncologist Santosh Kesari, MD, PhD, with “The Duke” Special Service Award, and philanthropist and President of Premier Girls Fastpitch Dan Hay with the Generation of Hope Award, at La Odisea, the 34th Odyssey Ball on May 4, 2019. Read more.[ Read More ] [ See All Posts ]
For the ever-growing number of patients with skull base and brain tumors, the need for better treatments and management strategies is acute. By combining laboratory and clinical data, we are able to provide therapies tailored to individual patients. Through clinical trials and research in conjunction with the Pacific Brain Tumor Center, we provide patients with customized advanced neuro-oncology and neurotherapeutic options. In addition, our integrated neurosciences and neurotherapeutics research program explores potential cancer cures through basic science, preclinical, clinical, and translational research.
Providence Saint John’s Health Center & John Wayne Cancer Institute
Our affiliated partners in research and clinical excellence.